Children/adolescents with mature B-cell non-Hodgkin lymphoma (B-NHL) have an excellent prognosis but relapses still occur. recurrences in the MRD-negative group (p=0.077). The study demonstrated molecular-disseminated disease in which Igprimer pools could be used to assess MD. This feasibility study supports future investigations to assess the validity and significance of MD testing in a more substantial… Continue reading Children/adolescents with mature B-cell non-Hodgkin lymphoma (B-NHL) have an excellent prognosis